AS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Buy now (pre-market ~$35.96): price is sitting just above key support (S1 ~$35.64), offering a reasonable entry without waiting for a \u201cperfect\u201d setup.", "Near-term technicals are still soft (bearish MACD), but options positioning and Wall Street targets skew strongly bullish, suggesting dip-buying interest and favorable medium-term upside.", "Catalyst window ahead: next earnings (QDEC 2025) on 2026-02-26 pre-market; Street sentiment is already positive going into the print."]
["Trend/momentum: MACD histogram -0.12 and negatively expanding \u2192 bearish momentum still building, so the move is not yet confirmed as a reversal.", "RSI(6)=36.8: weak/near-oversold territory but not a clear reversal signal; consistent with \u201cselling pressure slowing\u201d rather than \u201ctrend flipped.\u201d", "Moving averages: converging \u2192 transition zone; often precedes a larger move, but direction is not confirmed.", "Levels to watch: Support S1 ~$35.64 (then S2 ~$34.76). Resistance Pivot ~$37.07, then R1 ~$38.49. A reclaim of ~$37.07 would improve the bull case quickly."]
["Strong recent fundamentals (2025/Q3): revenue +29.7% YoY, net income +156.5% YoY, EPS +127.3% YoY; margin expansion supports the growth narrative.", "Analyst sentiment is consistently bullish with multiple Buy/Overweight ratings and raised targets (supports institutional demand on dips).", "Bullish options skew and unusually high options activity suggests traders are leaning toward upside exposure.", "Upcoming earnings catalyst: QDEC 2025 earnings on 2026-02-26 (pre-market), with EPS est. 0.27."]
means downside risk remains if support breaks.", "No Intellectia buy signals today (no AI Stock Picker and no SwingMax) \u2192 no proprietary confirmation of an immediate high-conviction entry.", "No recent news flow this week \u2192 fewer near-term narrative catalysts to force an immediate rerating before earnings.", "If ~$35.64 fails, next support is ~$34.76 (room for a quick drawdown)."]
["Latest quarter: 2025/Q3.", "Revenue: 1.756B, +29.73% YoY (strong top-line acceleration).", "Net income: 143.1M, +156.45% YoY (sharp profitability improvement).", "EPS: 0.25, +127.27% YoY (strong earnings leverage).", "Gross margin: 56.84%, +2.97% YoY (healthy margin expansion trend)."]
["Recent trend: ratings skew strongly positive (Buy/Overweight), with multiple price target increases/initiations from late 2025 into early 2026.", "Notable updates: UBS raised PT to $58 (Buy); Deutsche Bank resumed Buy with $49 PT; Barclays initiated Overweight with $49 PT; Wells Fargo raised PT to $45 (Overweight); Truist raised PT to $45 (Buy); Nomura upgraded to Buy with ~$39.8 PT.", "Wall St pros: multi-year growth runway (Arc'teryx/Salomon), earnings momentum, and margin/profitability scaling; some see EPS compounding potential.", "Wall St cons (from commentary): sensitivity/exposure concerns (e.g., China/brand cycle worries referenced by analysts historically) and near-term volatility risk\u2014though most still conclude upside outweighs."]
